The drugmaker named William Huyett as COO and Gina Consylman as SVP and CFO.
Whatever REDUCE-IT ultimately reveals (results from the completed study are expected in Q2 or Q3 2018), Salyer maintains Amarin has "a great story to tell, with or without the data."
The first year of the Trump administration was kind to pharma, but it might not be so fortunate in 2018.
Drugmakers have access to an abundance of data, but do they know how to use it to better communicate their stories and key messages? Michael Joachim, SVP, Growth and Innovation at Medicx, shares his insights with Larry Dobrow, MM&M senior editor.
Teva diminishes debt with job cuts and sale; FDA to study whether consumers can detect misleading ads; AbbVie, Roche present positive Phase-III data at ASH
The digital health startup was founded in 2015.
FDA issues prescription drug promotion guidance; FDA approves first follow-on biologic of Lilly's Humalog; drugmakers allegedly hired nurses to promote drugs
GCI Health has confirmed new hire Kath Kerry and maternity leave returner Rikki Jones as co-MDs of its London operation, the network's second hub alongside its New York headquarters.
Pfizer's Viagra generic to sell for half the price; GSK seeks oncology deals; Ionis' experimental Huntington's drug tackles toxic protein for the first time
Drugmakers are proud of the patient service programs they've developed. Yet there remains a disconnect in the way information is communicated to HCPs.
A study has found that channels certified by the Trustworth Accountability Group (TAG) had 83% less ad fraud than the broader industry average.
Cannes Lions' longtime leader, chief spokesman, and a figure many viewed as the heart and soul of the global creativity festival, will be moving on after the 2018 event ends.
FDA approves first nebulized LAMA COPD treatment; more than 2,000 cancer immunotherapies in development; FDA issues 3D-printing guidance
UnitedHealth Group to buy DaVita primary care unit for $4.9 billion; Roche drug combo doubles lung-cancer survival in trial; study: FDA programs expedite drug approval
DeVine will oversee the agency's health IT and medical device work.
Lighthouse received $50,000 for application aimed at providing more accessible and engaging care for those living with diabetes.
Next year will be the start of the shift from marketing algorithms to AI, predicts Kantar Millward Brown.
FDA approves Novo's diabetes drug; Walgreens undergoes rebranding in the wake of CVS-Aetna merger; pharma increasingly transparent about clinical trial data
Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds